Condition: Cervical Cancer · Locally Advanced Cervical Cancer · PD-L1 Negative · Sponsor: Tongji Hospital
This is a multicenter, prospective, single-arm, phase 2 clinical trial designed to evaluate the therapeutic efficacy of the NACI (neoadjuvant chemotherapy plus Camrelizumab) for PD-L1-negative locally advanced cervical cancer.
This description comes directly from the study's public registry record.
Kezhen Li · 086-027-8362 · tjkeke@126.com
Jie Yang · 086-027-8362 · yangjie@tjh.tjmu.edu.cn
Always discuss trial participation with your own doctor first.
| Anhui Provincial Cancer Hospital | Hefei, Anhui, China | Recruiting |
| Beiing Friendship Hospital, Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| The First Affiliated Hospital (Southwest Hospital), Army Medical University (Third Military Medical University) | Chongqing, Chongqing Municipality, China | Recruiting |
| Gansu Provincial Maternity and Child-care Hospital | Lanzhou, Gansu, China | Recruiting |
| The Affiliated Tumor Hospital of Guangxi Medical University | Nanning, Guangxi, China | Recruiting |
| Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan, Hubei, China | Recruiting |
| Xiangya Hospital, Central South University | Changsha, Hunan, China | Recruiting |
| Shengjing Hospital of China Medical University | Shenyang, Liaoning, China | Recruiting |
| Second People's Hospital of Sichuan (Sichuan Cancer Hospital) | Chengdu, Sichuan, China | Recruiting |
| Tianjin Medical University General Hospital | Tianjin, Tianjin Municipality, China | Recruiting |
| Women's Hospital, Zhejiang University School of Medicine | Hangzhou, Zhejiang, China | Recruiting |
| Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences | Hangzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06288360